Company / Profit Margin
Verrica Pharmaceuticals Inc. Profit Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-1012.1%
FY2025
5-year range
-1307.5% / -271.1%
FY2021-FY2025
Trend
+22.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -271.1% to -1012.1% over the past 2 years.
Based on SEC 10-K filings.
-1012.1% in FY2025 with a 3-year CAGR of -719.8%.
Declined from -271.1% to -1012.1% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -719.8pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 22.6% year-over-year.
- Peak profit margin was recorded in FY2023.
- Lowest profit margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1012.1% | +22.6% |
| FY2024 | -1307.5% | -382.3% |
| FY2023 | -271.1% | +7.3% |
| FY2022 | -292.3% | +17.8% |
| FY2021 | -355.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026